肺泡灌洗液中肿瘤标志物的联合检测在肺癌诊断中的价值

摘要

目的:探讨支气管肺泡灌洗液(BALF)3种肿瘤标志物癌胚抗原(CEA)、细胞角蛋白片段211(CYFRA211) 、神经元特异性烯醇化酶(NSE)对肺癌的临床诊断价值.方法:采用电化学发光法分别检测90例肺癌患者、60例肺部良性病变患者血清及BALF中CEA、CYFRA 211和NSE的含量.结果:肺癌患者BALF中3种肿瘤标志物的含量明显高于肺部良性病变患者(P＜0.05),且随着TNM临床分期升高,肿瘤标志物的含量也明显升高.在不同病理类型的肺癌中,3种肺癌肿瘤标志物升高的程度均有所不同.BALF中肿瘤标志物的含量与同期血清中的含量相比,出现更早且浓度更高.结论:肺癌患者BALF中CEA、CYFRA211、NSE联合检测对肺癌诊断有更高的临床参考价值.%Objective: To investigate the clinical value of 3 tumor markers [ carcinoma embryonic antigen ( CEA ),cytokeratin 19 fragments ( CYFRA211 ) and neuron specific enolase( NSE ) ]in bronchoalveolar lavage fluid ( BALF )to diagnose lung cancer. Methods:The levels of CEA、 CYFRA211 and NSE in BALF and serum were measured in 90 patients with lung cancer and 60 patients with benign lung disease by electro chemiluminescence. Results: The levels of 3 tumor markers in BALF were much higher in lung cancer group than that in benign lung disease group ( P ＜0.05 ) and they were higher in patients in stage Ⅲ and Ⅳ than those in stage Ⅰ and Ⅱ. The tumor markers increased to different degrees among the patients in various pathological classifications. It was also found that the levels of these tumor markers were higher and more sensitive in BALF than those in serum. Conclusion:The measurement of tumor markers in BALF is of more significant value than the measurement in serum, which helps early diagnosis, pathological classification and prognosis evaluation of lung cancer.